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Objectives. This study was undertaken to assess how prodromal
angina affects long-term prognosis after acute myocardial infarc-
tion.
Background. Although it has been reported that prodromal
angina occurring shortly before the onset of acute myocardial
infarction has protective effects against ischemia, its implication
for long-term prognosis remains unclear.
Methods. We studied consecutive 350 patients with anterior
myocardial infarction who underwent coronary angiography
within 24 h after the onset of chest pain. Follow-up was achieved
for 340 patients (97%).
Results. Eighty-nine patients had one or more episodes of
angina within 24 h before infarction. On initial angiography,
patients with prodromal angina in the 24 h before infarction had
a patent infarct-related artery more frequently than did those
without prodromal angina (34% vs. 22%, p 5 0.03). Among 213
patients who underwent thrombolytic therapy for an occluded
infarct-related artery, reperfusion was more frequently achieved
in patients with prodromal angina in the 24 h before infarction
(76% vs. 56%, p 5 0.01). Prodromal angina in the 24 h before
infarction was associated with a lower in-hospital mortality rate
(6% vs. 14%, p 5 0.02) and better 5-year survival (p 5 0.009).
There was no significant difference in survival between patients
with previous angina at any time (n 5 202) and those without.
Multivariate analysis showed that prodromal angina in the 24 h
before infarction was an independent factor related to 5-year
survival after acute myocardial infarction (odds ratio 0.49, p 5
0.04).
Conclusions. Prodromal angina occurring shortly before the
onset of infarction, but not previous angina itself, has a beneficial
effect on long-term prognosis after infarction, suggesting a rela-
tion to ischemic preconditioning.
(J Am Coll Cardiol 1997;30:970–5)
©1997 by the American College of Cardiology
Acute myocardial infarction is preceded by angina pectoris in
;50% of patients. It has been reported (1,2) that prodromal
angina pectoris occurring shortly before the onset of infarction
is associated with reduced infarct size and improved left
ventricular function. Experimental studies have shown that
brief episodes of ischemia shortly before prolonged coronary
occlusion reduce myocardial infarct size. This phenomenon is
termed “ischemic preconditioning” (3). However, recent clin-
ical studies have postulated other mechanisms: Thrombolytic
therapy may result in more rapid reperfusion in patients with
prodromal angina (4). A relation between prodromal angina
and intermittent occlusion of the infarct-related artery has
been also suggested (5). To assess this issue, we reviewed acute
angiographic findings in patients with acute myocardial infarc-
tion.
Although prodromal angina occurring shortly before infarc-
tion has been demonstrated in patients to have a favorable
effect on infarct size and left ventricular function, little is
known about its implication for survival after infarction. In the
current study, we also assessed the impact of prodromal angina
occurring shortly before the onset of infarction on short- and
long-term prognosis.
Methods
Study patients. Between January 1981 and December
1990, 350 patients with anterior wall acute myocardial infarc-
tion underwent coronary angiography within 24 h after the
onset of chest pain. We chose a 24-h time window because
recent studies (6,7) have reported that reperfusion initiated 6
to 24 h after the onset of chest pain prevents infarct expansion
and improves outcome. Anterior wall acute myocardial infarc-
tion was diagnosed by chest pain consistent with ongoing
myocardial ischemia persisting $30 min and associated with
$1-mm ST segment elevation in at least two adjacent precor-
dial electrocardiographic leads. Whether chest pain was still
present at the time of study entry was not examined (8). Serum
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creatine kinase was measured every 3 h for $24 h, and only
patients with peak creatine kinase value more than twice the
normal upper limit were admitted to the study.
Data were collected on the study form regarding whether
patients had ever experienced angina before myocardial infarc-
tion (previous angina at any time). Prodromal angina in the
24 h before infarction was defined as one or more typical chest
pain episodes persisting ,30 min either at rest or on effort
within 24 h before the onset of acute myocardial infarction.
Patients with stable angina pectoris were also included if they
had had one or more chest pain episodes within 24 h before
infarction. All patients with prodromal angina in the 24 h
before infarction were classified as having had previous angina
at any time.
Cardiac catheterization. Emergency cardiac catheteriza-
tion was performed by way of the right femoral artery after
heparin administration. Selective coronary angiography was
performed in multiple projections before the initiation of
reperfusion therapy. Immediately after diagnostic angiogra-
phy, thrombolytic therapy was performed with urokinase in 262
patients (75%). Usually, cumulative doses of urokinase were
infused up to 96 3 104 IU until reperfusion was achieved. After
thrombolytic therapy, 74 patients (21%) underwent immediate
angioplasty for residual stenosis and 48 patients (14%) under-
went rescue angioplasty for persistent occlusion of the artery.
Primary angioplasty without thrombolytic therapy was per-
formed in 61 patients (17%). The allocation of thrombolysis or
angioplasty was not randomized and was based on the physi-
cian’s decision. In general, thrombolytic therapy was per-
formed without adjunctive angioplasty during the 1st 4 years of
the study. During the last 6 years, angioplasty was performed
for severe stenosis after thrombolysis, after failed thrombolysis
or without thrombolytic therapy.
Angiographic analysis. All coronary angiograms were re-
viewed by two angiographers without knowledge of the clinical
variables. The perfusion status of the left anterior descending
coronary artery was determined in accordance with the Throm-
bolysis in Myocardial Infarction (TIMI) study classification (9).
An occluded artery was defined as TIMI flow grade #1.
Reperfusion was defined as TIMI flow grade $2. Initial TIMI
flow grade was assessed before the initiation of reperfusion
therapy and final TIMI flow grade from the final angiographic
frame. Multivessel coronary disease was defined as $75%
stenosis in one or more vessels remote from the infarct-related
artery. Left main coronary artery disease was considered to be
at least two-vessel involvement. The extent of collateral circu-
lation was assessed from the pretreatment angiogram and
classified in accordance with the method described by Rentrop
et al. (10); collateral circulation was considered to be present if
the grade was $2. Contrast left ventriculography was per-
formed in the 30° right anterior oblique projection at the time
of predischarge catheterization. Left ventricular ejection frac-
tion was calculated by the area-length method (11).
Follow-up. Follow-up was conducted between January and
April 1995. Follow-up was achieved for 340 patients (97%) by
review of a clinical record or a form mailed to the patients or
families determining the vital status of the patients. Data for a
full 5 years were available in most (317 of 340) patients.
Data analysis. Statistical analysis was performed with the
chi-square and t test. Kaplan-Meier estimates were used to
construct a long-term survival curve. Differences in 5-year
survival were assessed with the generalized Wilcoxon test. Cox
proportional hazards regression was used to identify indepen-
dent predictors of 5-year survival, assessing variables simulta-
neously including prodromal angina in the 24 h before infarc-
tion, previous angina at any time, age, gender, previous
infarction, hypertension, diabetes, Killip class, time to angiog-
raphy, initial arterial patency, collateral circulation, multivessel
disease and final reperfusion. Differences were considered
significant if the p value was , 0.05. All group data are
expressed as mean value 6SD.
Results
Clinical and angiographic characteristics (Table 1). Of the
350 patients, 89 (24%) had one or more episodes of angina
pectoris in the 24 h before the onset of acute myocardial
infarction. There was no difference in previous infarction, age,
gender, hypertension, diabetes or Killip class on admission
between patients with and without prodromal angina in the
24 h before the onset of infarction.
Average time from the onset of infarction to angiography
was 5.7 6 4.7 h. On initial coronary angiography, patients with
prodromal angina in the 24 h before infarction were more
likely to have a patent infarct-related artery (34% vs. 22%, p 5
0.03). There was no significant difference in prevalence of
collateral circulation or multivessel disease between patients
with and without prodromal angina in the 24 h before infarc-
tion.
Efficiency of reperfusion therapy. In the 262 patients who
underwent thrombolytic therapy, angiography was performed
5.3 6 4.3 h after the onset of infarction. After thrombolytic
therapy, reperfusion was more frequently achieved in patients
with than in those without prodromal angina in the 24 h before
infarction (80% vs. 60%, p 5 0.002). TIMI flow grade 3 was
obtained in 32% and 25% of these 262 patients, respectively
(p 5 0.28). Among these 262 patients, 213 (81%) had an
occluded infarct-related artery before the initiation of throm-
bolytic therapy. Among these 213 patients thrombolytic ther-
apy achieved reperfusion in 76% of those with prodromal
angina in the 24 h before infarction but in only 56% of those
without prodromal angina (p 5 0.01). TIMI flow grade 3 was
obtained in 24% and 19% of the patients, respectively (p 5
0.43). The average dose of urokinase used for thrombolytic
therapy was similar between patients with and without prodro-
mal angina in the 24 h before infarction (68 6 28 3 104 IU vs
68 6 28 3 104 IU, p 5 0.89).
Of the 262 patients treated with urokinase, 140 did not
undergo adjunctive angioplasty and their final TIMI flow grade
was assessed after thrombolysis. In these 140 patients, final
reperfusion was achieved in 81% of patients with prodromal
angina in the 24 h before infarction and in 65% of those
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without (p 5 0.06). Final TIMI flow grade 3 was recorded in
32% and 32%, respectively (p 5 0.96).
In 183 patients who underwent angioplasty, angiography
was performed 5.3 6 4.7 after the onset of infarction and final
TIMI flow grade was assessed after angioplasty. After angio-
plasty, there was no significant difference in the incidence of
reperfusion (96% vs. 91%, p 5 0.24), but TIMI flow grade 3
was more frequent in patients with prodromal angina in the
24 h before infarction (88% vs. 74%, p 5 0.04). When patients
who underwent rescue angioplasty (which was performed more
frequently in patients without prodromal angina in the 24 h
before infarction) were excluded, there was no significant
difference in the incidence of reperfusion (95% vs. 97%, p 5
0.70) or TIMI flow grade 3 (86% vs. 84%, p 5 0.72) between
the patients with and without prodromal angina in the 24 h
before infarction.
On the final angiograms of the 350 patients, reperfusion
was more frequently achieved in patients with than in those
without prodromal angina in the 24 h before infarction (90%
vs. 80%, p 5 0.03). The incidence of TIMI flow grade 3 was not
significantly different in the two groups (64% vs. 56%, p 5
0.18).
Of the 350 patients, 202 (58%) had at least one episode of
angina at any time before infarction. These patients had a
higher incidence of initial arterial patency (30% vs. 19%, p 5
0.02) and final reperfusion (87% vs. 77%, p 5 0.02) than did
patients without previous angina at any time. If patients with
prodromal angina in the 24 h before infarction were excluded,
there was no significant difference in initial patency (27% vs.
19%, p 5 0.14) and final reperfusion (84% vs. 77%, p 5 0.15)
between patients with and without previous angina at any time.
In-hospital outcome. Peak creatine kinase was obtained in
321 patients (92%) and averaged 2,583 6 1,880 IU/liter in 85
patients with prodromal angina in the 24 h before infarction
and 2,921 6 2,154 IU/liter in 236 patients without (p 5 0.20).
Predischarge left ventriculography was performed in 266 pa-
tients (76%): on an average of 23 6 9 days after infarction in
both the 80 patients (90%) with prodromal angina before
infarction and the 186 patients (71%) without prodromal
angina. Predischarge left ventricular ejection fraction was
56.5 6 15.6% in patients with prodromal angina in the 24 h
before infarction and 54.1 6 15.7% in those without (p 5
0.24).
During the hospital stay, 41 patients (12%) died: 21 of
pump failure, 11 from left ventricular wall rupture, 5 from
reinfarction, 3 from ventricular fibrillation and 1 from failure
of coronary angioplasty. Patients with prodromal angina in the
24 h before infarction had a lower in-hospital mortality rate
than those without prodromal angina (Table 2, 6% vs. 14%,
p 5 0.02). The incidence of ventricular tachycardia or ventric-
ular fibrillation was significantly lower in patients with prodro-
mal angina in the 24 h before infarction (2% vs. 8%, p 5
0.045). There was no significant difference between the two
groups in the incidence of postinfarction angina (26% vs. 17%,
p 5 0.07), reinfarction (3% vs. 6%, p 5 0.30). reocclusion (7%
vs. 10%, p 5 0.42) or pump failure (14% vs. 18%, p 5 0.28).
When only the 319 patients (91%) without previous infarction
were compared, there was still a tendency toward a lower
in-hospital mortality rate in patients with prodromal angina in
the 24 h before infarction (6% vs. 13%, p 5 0.06). In the 61
patients without reperfusion, the in-hospital mortality rate was
11% in the patients with prodromal angina and 31% in those
without (p 5 0.19).
Table 1. Clinical and Angiographic Characteristics of Patients
With Versus Those Without Prodromal Angina in the 24 h
Before Infarction
Prodromal Angina in the







Age (yr) 58 6 10 60 6 12 0.20 (NS)
Male gender 69 (78%) 214 (82%) 0.36 (NS)
Previous infarction 5 (6%) 26 (10%) 0.19 (NS)
Hypertension 33 (37%) 100 (38%) 0.84 (NS)
Diabetes 22 (25%) 47 (18%) 0.18 (NS)
Killip class $2 11 (12%) 39 (15%) 0.54 (NS)
Time to angiography (h) 6.0 6 5.0 5.5 6 4.6 0.44 (NS)
#6 h 59 (66%) 189 (72%) 0.28 (NS)
Initial TIMI flow grade
0 53 (60%) 187 (72%) 0.19 (NS)
1 6 (7%) 16 (6%)
2 15 (17%) 28 (11%)
3 15 (17%) 30 (11%)
Initial TIMI flow grade $2 30 (34%) 58 (22%) 0.03
Collateral circulation
0 28 (31%) 86 (33%) 0.80 (NS)
1 23 (26%) 74 (28%)
2 36 (40%) 92 (35%)
3 2 (2%) 9 (3%)
Collateral circulation $2 38 (43%) 101 (38%) 0.51 (NS)
Number of diseased vessels
0 1 (1%) 9 (3%) 0.30 (NS)
1 61 (69%) 167 (64%)
2 17 (19%) 65 (25%)
3 10 (8%) 20 (8%)
Multivessel disease 27 (30%) 85 (33%) 0.70 (NS)
Reperfusion therapy
Thrombolysis 66 (74%) 196 (75%) 0.86 (NS)
Intracoronary 53 (60%) 144 (55%) 0.47 (NS)
Intravenous 13 (15%) 53 (20%) 0.23 (NS)
PTCA 49 (55%) 134 (51%) 0.54 (NS)
Immediate PTCA 23 (26%) 51 (20%) 0.22 (NS)
Rescue PTCA 6 (7%) 42 (16%) 0.02
Primary PTCA 20 (22%) 41 (16%) 0.16 (NS)
None 3 (3%) 24 (9%) 0.05 (NS)
Final TIMI flow grade
0 5 (6%) 38 (15%) 0.11 (NS)
1 4 (4%) 14 (5%)
2 23 (26%) 63 (24%)
3 57 (64%) 146 (56%)
Final TIMI flow grade $2 80 (90%) 209 (80%) 0.03
Follow-up achieved 88 (90%) 252 (97%) 0.22 (NS)
Data presented are mean value 6 SD or number (%) of patients. PTCA 5
percutaneous transluminal coronary angioplasty; TIMI 5 Thrombolysis in
Myocardial Infarction.
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The in-hospital mortality rate was 9% in patients with
previous angina at any time and 15% in those without (p 5
0.08). In the 319 patients without previous infarction, the
in-hospital mortality rate was 10% and 14%, respectively (p 5
0.27). In the 61 patients without reperfusion, the in-hospital
mortality rate was 26% and 29%, respectively (p 5 0.76).
Long-term survival. During the 5-year follow-up period, 80
patients died. The 1-year survival rate was 86% and the 5-year
survival rate was 77%. Survival during the 5 years after
infarction was significantly better in patients with prodromal
angina in the 24 h before infarction than in those without (Fig.
1, p 5 0.009). However, there was no significant difference in
the 5-year survival rate between patients with previous angina
at any time and those without (Fig. 2, p 5 0.27).
A multivariate analysis was performed to assess predictors
of death during the 5-year follow-up period (Table 3). Prodro-
mal angina in the 24 h before infarction was an independent
predictor of 5-year survival among previous angina at any time,
age, gender, previous infarction, hypertension, diabetes, Killip
class, time to angiography, initial patency, collateral circula-
tion, multivessel disease and final reperfusion. Previous angina
at any time was not an independent predictor of survival.
Discussion
Present findings. The major findings of this study were 1)
prodromal angina in the 24 h before infarction was associated
with a patent infarct-related coronary artery before reperfu-
sion therapy and with reperfusion after thrombolytic therapy;
2) prodromal angina in the 24 h before infarction was associ-
ated with favorable in-hospital and 5-year survival rates, but
previous angina at any time was not; and 3) by a multivariate
analysis, prodromal angina in the 24 h before infarction and
final patency of the coronary artery were each independent
factors related to 5-year survival.
Previous studies. Several studies (12–16) have examined
implication of previous angina for prognosis after acute myo-
Table 2. In-Hospital, 1-Year and 5-Year Survival
Survival
In-Hospital 1 Year 5 Years
Prodromal angina in the 24 h
before infarction
Present
% 94% 94% 86%
No. 89 84 70
Absent
% 86% 83% 73%
No. 261 209 166
p value 0.02* 0.009†
Previous angina at any time
Present
% 91% 88% 79%
No. 202 174 143
Absent
% 85% 83% 74%
No. 148 119 93
p value 0.08* 0.27†
*Chi-square test for in-hospital survival. †Generalized Wilcoxon test for
survival during 5-year follow-up. Data presented are percent or number of
patients.
Figure 1. Five-year survival curves for patients with [Angina ,24 hr
(1)] versus those without [Angina ,24 hr (2)] prodromal angina in
the 24-h before infarction.
Figure 2. Five-year survival curves for patients with [Angina at any
time (1)] versus those without [Angina at any time (2)] previous
angina at any time.
Table 3. Multivariate Analysis Assessing Predictors of Death During
5-Year Follow-Up
Odds Ratio
(95% CI) p Value
Prodromal angina in the 24 h before
infarction
0.49 (0.23–0.98) 0.04
Previous angina at any time 1.26 (0.75–2.10) 0.38 (NS)
Age $65 yr 2.01 (1.28–3.44) 0.003
Male gender 0.86 (0.51–1.50) 0.58 (NS)
Previous infarction 0.90 (0.40–1.81) 0.78 (NS)
Hypertension 1.72 (1.05–2.81) 0.03
Diabetes 1.56 (0.85–2.78) 0.15 (NS)
Killip class $2 2.84 (1.66–4.72) ,0.001
Time to angiography #6 hr 0.83 (0.47–1.40) 0.49 (NS)
Initial TIMI flow grade $2 0.74 (0.36–1.43) 0.38 (NS)
Collateral circulation 0.64 (0.37–1.08) 0.10 (NS)
Multivessel disease 1.91 (1.16–3.16) 0.01
Final TIMI flow grade $2 0.24 (0.14–0.40) ,0.001
95% CI 5 95% confidence interval; TIMI 5 Thrombolysis in Myocardial
Infarction.
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cardial infarction. However, the results have been inconsistent:
Some investigators reported an association between previous
angina and a worse clinical outcome, but others reported a
lower mortality rate in patients with previous angina. More
important, there has been little study of the effect on mortality
of prodromal angina occurring shortly before infarction. Also,
there have been few data on angiographic findings before
initiation of reperfusion therapy in relation to prodromal
angina.
Recently, Kloner et al. (17) reviewed the results of the
TIMI 4 trial and reported fewer in-hospital deaths in patients
with than in those without prodromal angina occurring within
48 h before infarction. However, patients with previous angina
at any time also had fewer in-hospital deaths, suggesting that
having angina within 48 h before infarction did not confer
additional benefit. The reason for the inability of prodromal
angina in the 48 h before infarction to confer a beneficial effect
on clinical outcome may include the location of infarction and
the time interval from the last episode of angina to the onset of
infarction. Anzai et al. (18) reported that a favorable effect of
prodromal angina on infarct expansion and late phase left
ventricular function was observed only in patients with anterior
myocardial infarction but not in those with inferior infarction.
Nakakgawa et al. (2) reported that the time interval from the
last episode of angina to the onset of infarction was inversely
related to preserved myocardial contractile function, which
was greater in patients with prodromal angina within 24 h
before onset than in those without.
In the current study, we thus included only patients with
anterior myocardial infarction and demonstrated that prodro-
mal angina occurring within 24 h before infarction, but not
previous angina at any time, was associated with a lower
in-hospital mortality rate. The beneficial effect on mortality of
prodromal angina in the 24 h before infarction was sustained
throughout 5 years of follow-up study. To our knowledge, this
study is the first to demonstrate that prodromal angina occur-
ring shortly before infarction is associated with a favorable
short- and long-term prognosis after infarction.
Proposed mechanism. In the current study, we showed that
a patent infarct-related artery was more frequently observed in
patients with prodromal angina in the 24 h before infarction.
Previous studies (19) reported that coronary occlusion in the
early phase of myocardial infarction is frequently intermittent.
A larger proportion of these patients have prodromal angina.
Although it is unclear whether an initially patent infarct-
related artery is due to intermittent occlusion or to spontane-
ous reperfusion, the presence of a patent infarct-related artery
may contribute to a favorable prognosis in patients with
prodromal angina in the 24 h before infarction.
Recently, Andreotti et al. (4) demonstrated that thrombo-
lytic therapy resulted in more rapid reperfusion in patients who
had unstable angina during the week before infarction than in
those without preinfarction angina. In the current study, we
also showed that reperfusion was achieved more frequently in
patients with than in those without prodromal angina in the
24 h before infarction. Such a more efficient response of the
infarct-related artery to thrombolytic therapy may contribute
to a favorable prognosis in patients with prodromal angina in
the 24 h before infarction.
Despite these aforementioned findings, it is noteworthy that
a multivariate analysis taking into account initial and final
perfusion status of the infarct-related artery confirmed the
independent association of prodromal angina in the 24 h
before infarction with 5-year survival. This finding suggests
that prodromal angina in the 24 h before infarction in itself,
aside from patency of the infarct-related artery, has a benefi-
cial effect on clinical outcome. Also, patients without prodro-
mal angina in the 24 h before infarction tended to have a
higher incidence of previous infarction, and these patients
tended to be older than those with prodromal angina in the
24 h before infarction. The multivariate analysis showed that
prodromal angina in the 24 h before infarction was an inde-
pendent factor related to survival among these variables.
One potential mechanism that explains the association of
prodromal angina in the 24 h before infarction with a favorable
clinical outcome is ischemic preconditioning. Ischemic precon-
ditioning was first reported by Murry et al. (3). They demon-
strated in dogs that brief episodes of ischemia limited the size
of the infarct resulting from a subsequent coronary occlusion.
Previous clinical studies (20,21) suggested that ischemic pre-
conditioning may occur in patients with repetitive balloon
inflation during coronary angioplasty and with intermittent
aortic cross-clamping during coronary artery bypass surgery. In
the current study, infarct size assessed by peak creatine kinase
was somewhat smaller and left ventricular function assessed by
contrast left ventriculography was somewhat better in patients
with than in those without prodromal angina in the 24 h before
infarction. That these differences were not statistically signifi-
cant may be due to the small sample size of our study. Another
possible explanation for the absence of a demonstrated differ-
ence in left ventricular function in the two groups is that left
ventriculography was not performed in 84 patients. Predis-
charge ventriculography was missed in only 10% of the patients
with prodromal angina but in 29% of those without. Most
patients in whom ventriculography was not performed died
during the hospital stay and may have had poorer left ventric-
ular function.
It was previously reported (22) that prodromal angina
reduced the occurrence of life-threatening ventricular tachyar-
rhythmias. Similarly, in the current study, the incidence of
ventricular tachycardia and fibrillation was significantly lower
in patients with prodromal angina in the 24 h before infarction
than in those without. Reduction of life-threatening arrhyth-
mias may contribute to favorable survival in patients with
prodromal angina.
Study limitations. This study suffers from limitations com-
mon to all nonrandomized, retrospective analyses. The alloca-
tion of reperfusion therapy was based on the physician’s
decision, and some patients did not receive thrombolytic
therapy. However, the subgroup of patients who underwent
thrombolytic therapy had clinical and angiographic baseline
characteristics similar to those of the total group. Also, the
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dose of urokinase in each patient who underwent thrombolytic
therapy was not controlled. However, it is noteworthy that the
average dose of urokinase used was similar between patients
with and without prodromal angina in the 24 h before infarc-
tion. With a similar dose of urokinase, reperfusion was more
frequently achieved in patients with prodromal angina in the
24 h before infarction.
Follow-up was not achieved for 10 patients, all of whom
could not be located because they had died. However, only 1 of
the 10 had had prodromal angina in the 24 h before infarction.
An analysis in which this patient with prodromal angina was
classified as dead on the day after hospital discharge and the
remaining nine patients were classified as alive at 5 years also
showed a significantly better 5-year survival rate for patients
with than for those without prodromal angina in the 24 h
before infarction (p 5 0.02).
In this study, only the presence of prodromal angina in the
24 h before infarction was examined. Whether prodromal
angina within 48 h to 7 days could favorably alter outcome was
not assessed. Also, follow-up was conducted determining vital
status of the patients, and data on previous medications were
not obtained.
Conclusions. Prodromal angina occurring shortly before
the onset of infarction, but not previous angina itself, has a
beneficial effect on long-term prognosis after infarction, sug-
gesting a relation to ischemic preconditioning.
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